Compare CLLS & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | PKBK |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 269.2M |
| IPO Year | 2007 | N/A |
| Metric | CLLS | PKBK |
|---|---|---|
| Price | $4.40 | $25.14 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 133.9K | 38.2K |
| Earning Date | 11-07-2025 | 01-23-2026 |
| Dividend Yield | N/A | ★ 2.87% |
| EPS Growth | N/A | ★ 21.56 |
| EPS | N/A | ★ 2.83 |
| Revenue | ★ $82,551,000.00 | $71,766,000.00 |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.85 |
| Revenue Growth | ★ 129.04 | 13.64 |
| 52 Week Low | $1.10 | $16.94 |
| 52 Week High | $5.48 | $25.77 |
| Indicator | CLLS | PKBK |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 71.06 |
| Support Level | $4.47 | $23.72 |
| Resistance Level | $5.45 | $25.77 |
| Average True Range (ATR) | 0.30 | 0.50 |
| MACD | -0.12 | 0.08 |
| Stochastic Oscillator | 31.17 | 74.68 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.